Comparing the gene signatures to the cancer-associated patient-specific MSCs isolated in our study provide evidence that the patient-derived cluster of cells (C7) had an increased level of COL10A1 expression; thus, these cells may be the source of COL10A1 expression in the tumor (Fig 5D). This evidence concerns the gene COL10A1 and cancer.